Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer

被引：0
|
作者：
Markus Dietlein
Carsten Kobe
Georg Kuhnert
Simone Stockter
Thomas Fischer
Klaus Schomäcker
Matthias Schmidt
Felix Dietlein
Boris D. Zlatopolskiy
Philipp Krapf
Raphael Richarz
Stephan Neubauer
Alexander Drzezga
Bernd Neumaier
机构：
[1] University Hospital of Cologne,Department of Nuclear Medicine
[2] University Hospital of Cologne,Institute of Radiochemistry and Experimental Molecular Imaging
[3] University Hospital of Cologne,Center of Integrated Oncology Cologne Bonn
[4] “Klinik am Ring”,Western German Prostata Center
来源：
Molecular Imaging and Biology | 2015年 / 17卷
关键词：
Prostate-specific membrane antigen (PSMA); F-18; Ga-68; Positron emission tomography (PET); Prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：575 / 584
页数：9
相关论文
共 50 条
  • [31] First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CT
    Verburg, Frederik A.
    Krohn, Thomas
    Heinzel, Alexander
    Mottaghy, Felix M.
    Behrendt, Florian F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (10) : 1622 - 1623
  • [32] 68Ga-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancer
    Elif Neslihan Akdemir
    Murat Tuncel
    Fadıl Akyol
    Cenk Yucel Bilen
    Dilek Ertoy Baydar
    Erdem Karabulut
    Haluk Ozen
    Meltem Caglar
    World Journal of Urology, 2019, 37 : 813 - 821
  • [33] 68Ga or 18F for Prostate Cancer Imaging
    Kesch, Claudia
    Kratochwil, Clemens
    Mier, Walter
    Kopka, Klaus
    Giesel, Frederik L.
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (05) : 687 - 688
  • [34] Integrated 68Ga-HBED-CC-PSMA-PET/MRI in patients with suspected recurrent prostate cancer
    Luetje, Susanne
    Cohnen, Joseph
    Gomez, Benedikt
    Grueneisen, Johannes
    Sawicki, Lino M.
    Ruebben, Herbert
    Bockisch, Andreas
    Umutlu, Lale
    Poeppel, Thorsten D.
    Wetter, Axel
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2017, 56 (03): : 73 - 81
  • [35] 68Ga-labelled PSMA ligand HBED-CC PET/CT imaging in patients with recurrent prostate cancer
    Akdemir, Elif Neslihan
    Tuncel, Murat
    Akyol, Fadil
    Bilen, Cenk Yucel
    Baydar, Dilek Ertoy
    Karabulut, Erdem
    Ozen, Haluk
    Caglar, Meltem
    WORLD JOURNAL OF UROLOGY, 2019, 37 (05) : 813 - 821
  • [36] MR PET scan with 68GA PSMA in prostate cancer
    Lo, R.
    Lo, C.
    Chan, J.
    Cheung, W.
    Lo, G.
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 : 84 - 85
  • [37] MR PET scan with 68Ga PSMA in prostate cancer
    Lo, R. K.
    Lo, C. S.
    Chan, J. K.
    Cheung, W. S.
    Lo, G. G.
    BJU INTERNATIONAL, 2017, 119 : 7 - 7
  • [38] IMPACT OF DELAYED IMAGING ON INTERPRETATION OF [68GA]-PSMA PET IN PROSTATE CANCER
    Schembri, G.
    Zhou, W.
    Bailey, D. L.
    Kneebone, A.
    Eade, T.
    Roach, P.
    Hsiao, E.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 16 - 16
  • [39] Histology correlation of in vivo [68Ga]PSMA-PET/MRI data of the prostate
    Sandgren, K.
    Jonsson, J.
    Nyholm, T.
    Strandberg, S.
    Ogren, M.
    Axelsson, J.
    Blomqvist, L.
    Freidrich, B.
    Bergh, A.
    Riklund, K. Ahlstrom
    Windmark, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S541 - S541
  • [40] Prospective Comparison of [18F]FDG and [68Ga]Ga-PSMA PET/CT in Staging Multiple Myeloma
    Di Franco, M.
    Bezzi, D.
    Talarico, M.
    Zamagni, E.
    Cabitza, V.
    Filippo, L.
    Fanti, S.
    Nanni, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S308 - S308
12345